H1 receptor antagonists reduced tumor growth, mast cell infiltration, and VEGF levels through the inhibition of hypoxia-inducible factor-1alpha (HIF-1α) in melanoma-bearing mice (37). This evidence concerns the gene VEGFA and neoplasm.